Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
18 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Simulect“
Suchtreffer
Begriffe & Kennungen
Simulect · 4.8 · Incidence of malignant neoplasms: The overall incidence of malignancies among all patients in the individual s
Eintrag öffnenSimulect · 4.8 · Incidence of malignant neoplasms: The overall incidence of malignancies among all patients in the individual s
Eintrag öffnenSimulect · 4.8 · Listing of adverse reactions from post-marketing spontaneous reports
Eintrag öffnenSimulect · 4.8 · Listing of adverse reactions from post-marketing spontaneous reports
Eintrag öffnenSimulect · 4.8 · Paediatric population
Eintrag öffnenSimulect · 4.8 · Paediatric population
Eintrag öffnenSimulect · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenSimulect · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenSimulect · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenSimulect · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenSimulect · 4.8 · The following adverse reactions have been identified based on post-marketing spontaneous reports and are organ
Eintrag öffnenSimulect · 4.8 · The following adverse reactions have been identified based on post-marketing spontaneous reports and are organ
Eintrag öffnenSimulect · 4.8 · The incidence and causes of deaths following dual or triple therapy were similar in basiliximab (2.9%) and pla
Eintrag öffnenSimulect · 4.8 · The incidence and causes of deaths following dual or triple therapy were similar in basiliximab (2.9%) and pla
Eintrag öffnenSimulect · 4.8 · The most commonly reported (> 20%) events following dual or triple therapy in both treatment groups (basilixim
Eintrag öffnenSimulect · 4.8 · The most commonly reported (> 20%) events following dual or triple therapy in both treatment groups (basilixim
Eintrag öffnenSimulect · 4.8 · The most commonly reported (> 20%) events following dual therapy in both (< 35 kg vs. 35 kg weight) cohorts
Eintrag öffnenSimulect · 4.8 · The most commonly reported (> 20%) events following dual therapy in both (< 35 kg vs. 35 kg weight) cohorts
Eintrag öffnen